At the moment, immunotherapy has only been demonstrated to be effective with certain forms of
cancer, although there is a strong sense of hope among clinicians and researchers that immunotherapy will provide solutions for the broadest set of patients possible. Research is still needed to determine the optimal parameters for immuno-oncology therapies across the range of sites, grades, and tissue type.